Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

104
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
104
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

97
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
97
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

147
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
147
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

93
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
93
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

414
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
414

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Werner Irnich: Pioneer in the Development of the Dual-Chamber Pacemaker-An Obituary.

Pacing and clinical electrophysiology : PACE·2026
Same author

Unexpected twist: large marginal branch occlusion of the left circumflex artery unveiled by immediate and pivotal cardiac magnetic resonance imaging in a 19-year-old with suspected myocarditis-a case report.

European heart journal. Case reports·2026
Same author

[2023 Annual Report of the German Pacemaker and Defibrillator Register-Part 2: Implantable cardioverter defibrillators (ICD)].

Herzschrittmachertherapie & Elektrophysiologie·2026
Same author

[Annual report 2023 of the German Pacemaker and Defibrillator Register-Part 1: Cardiac pacemaker].

Herzschrittmachertherapie & Elektrophysiologie·2026
Same author

Cardiac implantable electronic device upgrades and downgrades: a Clinical Consensus Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Asia Pacific Heart Rhythm Association (APHRS), Canadian Heart Rhythm Society (CHRS), Heart Rhythm Society (HRS), and the Latin American Heart Rhythm Society (LAHRS).

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2025
Same author

[Resynchronization of left bundle branch block by His bundle pacing : A case series].

Herzschrittmachertherapie & Elektrophysiologie·2025

Related Experiment Video

Updated: Nov 9, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.9K

[Perioprocedural mortality after ICD implantation].

Harilaos Bogossian1,2, Dimitrios Panteloglou3, Zana Karosiene3

  • 1Klinik für Kardiologie und Rhythmologie, Ev. Krankenhaus Hagen, Brusebrinkstr. 20, 58135, Hagen, Deutschland. bogossianh@esv.de.

Herz
|April 16, 2021
PubMed
Summary

Implantable cardioverter defibrillator (ICD) implantation has a low mortality risk (0.6%). Higher risks are seen in elderly patients, women, those with advanced heart failure, renal failure, or undergoing secondary prevention.

Keywords:
ComplicationsDefibrillatorsQuality assuranceRisk factorsSurgery

More Related Videos

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.9K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.4K

Related Experiment Videos

Last Updated: Nov 9, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.9K
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.9K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.4K

Area of Science:

  • Cardiology
  • Medical Device Technology
  • Public Health

Background:

  • Implantable cardioverter defibrillators (ICDs) are crucial for preventing sudden cardiac death.
  • ICD implantation, like any surgery, carries inherent risks, including mortality.
  • Understanding procedure-related mortality is vital for patient safety and quality assurance.

Purpose of the Study:

  • To analyze the procedure-related mortality associated with ICD implantation.
  • To identify patient demographics and clinical factors influencing mortality after ICD procedures.
  • To utilize data from a mandatory quality assurance program for comprehensive analysis.

Main Methods:

  • Analysis of 18,625 patient records from quality assurance datasets (2010-2012).
  • Inclusion of all patients undergoing ICD implantation within the specified period.
  • Statistical analysis to determine mortality rates and associated risk factors.

Main Results:

  • Overall in-hospital mortality was 0.6% (118 patients).
  • Increased mortality observed in patients over 80 years (1.9%), women (0.95%), and those with higher NYHA class (up to 3.4%).
  • Renal failure requiring dialysis and secondary prevention indications significantly increased mortality risk.

Conclusions:

  • Procedure-related mortality after ICD implantation is elevated in specific patient groups.
  • Risk factors include advanced age, higher NYHA class, renal failure, secondary prevention, and perioperative complications.
  • These findings underscore the importance of careful patient selection and risk management.